PFM Health Sciences, LP - Q1 2020 holdings

$1.22 Billion is the total value of PFM Health Sciences, LP's 61 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 91.8% .

 Value Shares↓ Weighting
ALXN SellALEXION PHARMACEUTICALS INC$61,618,000
-47.1%
686,249
-36.2%
5.06%
-8.7%
ABBV BuyABBVIE INC$55,175,000
+274.9%
724,174
+335.6%
4.53%
+546.4%
ANTM BuyANTHEM INC$50,840,000
-15.2%
223,925
+12.8%
4.18%
+46.2%
MCK NewMCKESSON CORP$46,523,000343,950
+100.0%
3.82%
NewBIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0$43,421,00041,600,000
+100.0%
3.57%
CAH NewCARDINAL HEALTH INC$42,117,000878,531
+100.0%
3.46%
GILD SellGILEAD SCIENCES INC$41,368,000
-52.9%
553,339
-59.1%
3.40%
-18.8%
ICUI BuyICU MED INC$40,826,000
+31.7%
202,339
+22.1%
3.35%
+127.0%
PFE BuyPFIZER INC$38,537,000
+6.5%
1,180,658
+27.9%
3.16%
+83.7%
KRTX SellKARUNA THERAPEUTICS INC$35,965,000
-20.8%
499,510
-17.1%
2.95%
+36.6%
BDX NewBECTON DICKINSON & CO$34,730,000151,150
+100.0%
2.85%
CI SellCIGNA CORP NEW$34,495,000
-36.5%
194,690
-26.7%
2.83%
+9.5%
AERI BuyAERIE PHARMACEUTICALS INC$34,132,000
-41.5%
2,528,276
+4.8%
2.80%
+0.9%
BMRN SellBIOMARIN PHARMACEUTICAL INC$33,767,000
-27.9%
399,605
-27.8%
2.77%
+24.3%
HUM BuyHUMANA INC$32,353,000
+11.0%
103,030
+29.5%
2.66%
+91.3%
ARNA SellARENA PHARMACEUTICALS INC$31,467,000
-35.3%
749,217
-30.0%
2.58%
+11.6%
ABC NewAMERISOURCEBERGEN CORP$29,978,000338,732
+100.0%
2.46%
HRTX NewHERON THERAPEUTICS INC$29,138,0002,481,917
+100.0%
2.39%
UNH BuyUNITEDHEALTH GROUP INC$26,116,000
-6.2%
104,722
+10.6%
2.14%
+61.8%
BIIB SellBIOGEN INC$25,631,000
-62.2%
81,013
-64.5%
2.10%
-34.8%
BAX NewBAXTER INTL INC$25,139,000309,635
+100.0%
2.06%
VRTX BuyVERTEX PHARMACEUTICALS INC$22,720,000
+82.3%
95,482
+67.7%
1.87%
+214.1%
EW BuyEDWARDS LIFESCIENCES CORP$22,331,000
-7.3%
118,392
+14.6%
1.83%
+59.8%
JNJ NewJOHNSON & JOHNSON$21,817,000166,375
+100.0%
1.79%
PEN SellPENUMBRA INC$19,068,000
-72.3%
118,190
-71.8%
1.57%
-52.2%
IRTC SellIRHYTHM TECHNOLOGIES INC$18,988,000
-39.1%
233,409
-49.1%
1.56%
+4.9%
CNC SellCENTENE CORP DEL$18,265,000
-64.5%
307,441
-62.5%
1.50%
-38.9%
MOH SellMOLINA HEALTHCARE INC$17,386,000
-27.6%
124,444
-29.7%
1.43%
+24.8%
IQV SellIQVIA HLDGS INC$16,956,000
-68.1%
157,201
-54.2%
1.39%
-44.9%
HCA SellHCA HEALTHCARE INC$16,699,000
-59.6%
185,849
-33.5%
1.37%
-30.3%
NVDA BuyNVIDIA CORP$16,302,000
+73.7%
61,842
+55.0%
1.34%
+199.6%
MSFT BuyMICROSOFT CORP$15,010,000
+33.4%
95,177
+33.4%
1.23%
+130.0%
IMMU SellIMMUNOMEDICS INC$14,343,000
-54.8%
1,064,041
-29.0%
1.18%
-22.0%
RETA NewREATA PHARMACEUTICALS INCcl a$14,126,00097,864
+100.0%
1.16%
BABA BuyALIBABA GROUP HLDG LTDsponsored ads$13,630,000
+44.7%
70,083
+57.8%
1.12%
+149.2%
ICLR SellICON PLC$12,573,000
-62.3%
92,446
-52.2%
1.03%
-34.9%
SAGE NewSAGE THERAPEUTICS INC$12,536,000436,477
+100.0%
1.03%
RCUS NewARCUS BIOSCIENCES INC$11,236,000809,511
+100.0%
0.92%
HALO BuyHALOZYME THERAPEUTICS INC$11,131,000
+5.8%
618,726
+4.3%
0.91%
+82.4%
AMZN NewAMAZON COM INC$10,415,0005,342
+100.0%
0.86%
CNST NewCONSTELLATION PHARMCETICLS I$9,929,000315,894
+100.0%
0.82%
XLNX NewXILINX INC$9,717,000124,677
+100.0%
0.80%
SellMORPHOSYS AGsponsored ads$9,270,000
-40.2%
102,941
-15.8%
0.76%
+3.1%
IGMS NewIGM BIOSCIENCES INC$9,158,000163,105
+100.0%
0.75%
ALNY NewALNYLAM PHARMACEUTICALS INC$8,904,00081,804
+100.0%
0.73%
PPD NewPPD INC$8,509,000477,743
+100.0%
0.70%
DCPH NewDECIPHERA PHARMACEUTICALS IN$8,495,000206,336
+100.0%
0.70%
CHRS SellCOHERUS BIOSCIENCES INC$7,689,000
-20.2%
474,055
-11.4%
0.63%
+37.5%
FLDM SellFLUIDIGM CORP DEL$6,790,000
-39.7%
2,673,090
-17.4%
0.56%
+4.1%
IMMU NewIMMUNOMEDICS INCcall$6,035,000447,700
+100.0%
0.50%
DE NewDEERE & CO$5,555,00040,208
+100.0%
0.46%
XLRN NewACCELERON PHARMA INC$5,518,00061,400
+100.0%
0.45%
ZLAB NewZAI LAB LTDadr$4,344,00084,387
+100.0%
0.36%
SHOP NewSHOPIFY INCcl a$3,942,0009,454
+100.0%
0.32%
INSM NewINSMED INC$3,667,000228,781
+100.0%
0.30%
NEE NewNEXTERA ENERGY INC$3,205,00013,320
+100.0%
0.26%
COUP BuyCOUPA SOFTWARE INC$2,922,000
+105.3%
20,909
+114.9%
0.24%
+252.9%
NewACORDA THERAPEUTICS INCnote 1.750% 6/1$1,721,0002,000,000
+100.0%
0.14%
MYOK NewMYOKARDIA INC$1,669,00035,592
+100.0%
0.14%
ACOR SellACORDA THERAPEUTICS INC$1,423,000
-63.2%
1,526,174
-19.4%
0.12%
-36.4%
ALNA NewALLENA PHARMACEUTICALS INC$274,000284,285
+100.0%
0.02%
ELGXQ ExitENDOLOGIX INC$0-159,285
-100.0%
-0.01%
VC ExitVISTEON CORP$0-20,313
-100.0%
-0.08%
PYPL ExitPAYPAL HLDGS INC$0-19,076
-100.0%
-0.10%
INTU ExitINTUIT$0-16,747
-100.0%
-0.21%
SQ ExitSQUARE INCcl a$0-80,427
-100.0%
-0.24%
NXPI ExitNXP SEMICONDUCTORS N V$0-62,249
-100.0%
-0.38%
MCHP ExitMICROCHIP TECHNOLOGY INC$0-81,671
-100.0%
-0.41%
BIIB ExitBIOGEN INCcall$0-30,300
-100.0%
-0.43%
CRM ExitSALESFORCE COM INC$0-63,398
-100.0%
-0.49%
AMRN ExitAMARIN CORP PLCspons adr new$0-533,421
-100.0%
-0.54%
CSII ExitCARDIOVASCULAR SYS INC DEL$0-274,689
-100.0%
-0.64%
AXNX ExitAXONICS MODULATION TECH INC$0-550,026
-100.0%
-0.73%
CTLT ExitCATALENT INC$0-316,962
-100.0%
-0.85%
EXAS ExitEXACT SCIENCES CORP$0-209,839
-100.0%
-0.92%
ExitBIOMARIN PHARMACEUTICAL INCnote 1.500%10/1$0-18,275,000
-100.0%
-0.94%
NVST ExitENVISTA HLDGS CORP$0-825,732
-100.0%
-1.17%
BPMC ExitBLUEPRINT MEDICINES CORPput$0-336,800
-100.0%
-1.28%
VRTX ExitVERTEX PHARMACEUTICALS INCcall$0-126,200
-100.0%
-1.32%
ABT ExitABBOTT LABS$0-322,713
-100.0%
-1.34%
ExitDERMIRA INCnote 3.000% 5/1$0-30,558,000
-100.0%
-1.35%
DERM ExitDERMIRA INC$0-2,271,180
-100.0%
-1.64%
NVS ExitNOVARTIS A Gsponsored adr$0-442,640
-100.0%
-1.94%
AGN ExitALLERGAN PLC$0-281,548
-100.0%
-2.56%
ZBH ExitZIMMER BIOMET HLDGS INC$0-442,627
-100.0%
-3.16%
NVRO ExitNEVRO CORP$0-577,163
-100.0%
-3.23%
BOLD ExitAUDENTES THERAPEUTICS INC$0-1,232,873
-100.0%
-3.51%
CI ExitCIGNA CORP NEWcall$0-519,500
-100.0%
-5.06%
GILD ExitGILEAD SCIENCES INCcall$0-3,024,200
-100.0%
-9.36%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MOLINA HEALTHCARE INC41Q3 20232.2%
HCA HOLDINGS INC38Q3 20235.2%
HUMANA INC37Q3 20233.8%
EDWARDS LIFESCIENCES CORP36Q3 20233.3%
UNITEDHEALTH GROUP INC33Q3 20234.8%
PENUMBRA INC33Q3 20234.8%
AERIE PHARMACEUTICALS INC28Q2 20223.7%
TENET HEALTHCARE CORP27Q3 20232.3%
ELEVANCE HEALTH INC26Q3 20234.2%
ICON PLC26Q3 20232.5%

View PFM Health Sciences, LP's complete holdings history.

Latest significant ownerships (13-D/G)

View PFM Health Sciences, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G2023-04-21

View PFM Health Sciences, LP's complete filings history.

Compare quarters

Export PFM Health Sciences, LP's holdings